Condition
Rhinoconjunctivitis clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Rhinoconjunctivitis clinical trials that are recruiting, at sites in 4 countries (most in Spain (4), Argentina (1), China (1)). By phase: Phase 3 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Rhinoconjunctivitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sublingual MM09 for dust-mite–triggered rhinitis and rhinoconjunctivitis in people aged 12–65 with or without mild-to-moderate asthma | Phase 3 | Nueve de Julio, Buenos Aires and 18 other locations | Recruiting | Jan 16, 2026 |
| Evaluating a new treatment for allergies to certain trees and grasses | Phase 3 | Valladolid, Castille and León and 26 other locations | Recruiting | May 24, 2021 |
| Evaluating a treatment for allergies to grass and olive pollen | Phase 3 | Tarancón, Cuenca and 31 other locations | Recruiting | May 18, 2021 |
| Evaluating a treatment for allergies to dust mites | Phase 3 | Santiago de Compostela, A Coruña and 31 other locations | Recruiting | Jun 17, 2020 |
All recruiting trials (4)
-
Sublingual MM09 for dust-mite–triggered rhinitis and rhinoconjunctivitis in people aged 12–65 with or without mild-to-moderate asthma
This trial will test whether daily sublingual MM09 reduces symptoms and the need for rescue medication in people aged 12–65 who have rhinitis or rhinoconjunctivitis caused by dust mites, with or without mild-to-moderate asthma.
-
Evaluating a new treatment for allergies to certain trees and grasses
This study is testing a new allergy treatment for people aged 12 to 65 who are sensitive to certain tree and grass pollens to see if it can help reduce their allergy symptoms.
-
Evaluating a treatment for allergies to grass and olive pollen
This study is testing a new allergy treatment for people aged 12 to 65 who have reactions to grass and olive pollen to see if it can help reduce their symptoms.
-
Evaluating a treatment for allergies to dust mites
This study is testing a new allergy treatment for people aged 12 to 65 who are sensitive to dust mites to see if it can help reduce their allergy and asthma symptoms over a year.
Related topics
Quick answers
How many Rhinoconjunctivitis clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Spain (4 trials), Argentina (1 trial), China (1 trial), Portugal (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.